Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Effects of PDE10A inhibitor MK-8189 in people with an acute episode of schizophrenia: A randomized proof-of-concept clinical trial.
Journal: Schizophrenia research
Published: September 22, 2023
Progression from Prodromal Alzheimer's Disease to Mild Alzheimer's Disease Dementia in the Verubecestat APECS Study: Adjudicating Diagnostic Transitions.
Journal: Journal of Alzheimer's disease : JAD
Published: February 06, 2023
An Exploratory Study Using Electronic Medical Records to Assess the Feasibility of Establishing Cohorts of Patients with Genetic Causes of Parkinson's Disease.
Journal: Journal of Parkinson's disease
Published: April 25, 2022
Sugammadex for reversal of neuromuscular blockade in pediatric patients: Results from a phase IV randomized study.
Journal: Paediatric anaesthesia
Published: August 03, 2021
Medications in Patients with Dementia and Behavioral Disturbance.
Journal: Journal of Alzheimer's disease reports
Published: May 19, 2021
Cognitive outcomes in trials of two BACE inhibitors in Alzheimer's disease.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: March 26, 2020
Making Better Dose Decisions: Using Exposure-Response Modeling to Integrate Efficacy Outcome of Two Phase IIb Clinical Trials of Ubrogepant for Migraine Treatment.
Journal: Clinical and translational science
Published: September 09, 2019
BACE inhibition causes rapid, regional, and non-progressive volume reduction in Alzheimer's disease brain.
Journal: Brain : a journal of neurology
Published: August 20, 2019
Randomized Trial of Verubecestat for Prodromal Alzheimer's Disease.
Journal: The New England journal of medicine
Published: April 11, 2019
Further analyses of the safety of verubecestat in the phase 3 EPOCH trial of mild-to-moderate Alzheimer's disease.
Journal: Alzheimer's research & therapy
Published: March 19, 2019
Randomized, controlled, proof-of-concept trial of MK-7622 in Alzheimer's disease.
Journal: Alzheimer's & dementia (New York, N. Y.)
Published: June 30, 2018
Randomized Trial of Verubecestat for Mild-to-Moderate Alzheimer's Disease.
Journal: The New England journal of medicine
Published: May 03, 2018
Last Updated: 09/26/2026